Clinical Scorecard: Indiana Community Advocates for Continuation of Needle Exchange Program Following Presidential Directive
At a Glance
Category
Detail
Condition
Intravenous drug use and associated infectious diseases (HIV, hepatitis C)
Key Mechanisms
Harm reduction via syringe exchange programs providing sterile needles, naloxone, testing, and referrals to treatment
Target Population
Intravenous drug users at risk of infectious disease and overdose
Care Setting
Community health departments and syringe services programs
Key Highlights
Syringe exchange programs reduce HIV and hepatitis C incidence by approximately 50% and have a 92% syringe return rate in Clark County.
Federal restrictions limit funding for supplies like cookers and tourniquets, but programs use private funds to continue distribution.
Programs provide comprehensive services including naloxone distribution, disease testing, and referrals to drug treatment, improving public health outcomes.
Guideline-Based Recommendations
Diagnosis
Offer HIV and hepatitis C testing to intravenous drug users at syringe exchange sites.
Management
Provide sterile needles and injection supplies to prevent disease transmission.
Distribute naloxone to reverse opioid overdoses.
Offer education, counseling, and referrals to drug treatment programs.
Monitoring & Follow-up
Track syringe return rates to assess program engagement and effectiveness.
Monitor overdose reversals and referrals to treatment services.
Risks
Potential political and funding challenges may limit access to sterile supplies.
Risk of continued intravenous drug use despite harm reduction efforts.
Patient & Prescribing Data
Intravenous drug users participating in syringe exchange programs
Programs have facilitated over 27,000 treatment referrals and nearly 25,000 naloxone overdose reversals statewide, demonstrating effectiveness in harm reduction and linkage to care.
Clinical Best Practices
Maintain nonjudgmental, compassionate engagement with participants to encourage treatment readiness.
Utilize private funding sources to sustain supply distribution when federal funds are restricted.
Integrate comprehensive services including testing, education, and social support referrals within syringe exchange programs.
